Results 91 to 100 of about 11,214 (119)

恩替卡韦联合糖皮质激素治疗乙肝病毒相关性肾炎的临床观察

open access: yesLinchuang shenzangbing zazhi, 2013
目的 观察恩替卡韦联合糖皮质激素治疗乙型肝炎(乙肝)病毒相关性肾炎的临床效果。方法 选取在我完住院的乙肝病毒相关性肾炎患者65例,将患者随机分成2组。单一抗病毒组30例,单用恩替卡韦抗病毒治疗。联合治疗组35例,恩替卡韦抗病毒联合适量、短期糖皮质激素治疗。2组均给予常规护肝、降酶及保护肾功能治疗。对所有患者治疗前、后乙肝病毒DNA、肝功能、肾功能、血尿常规进行测定。结果 在抗病毒、护肝方面,治疗12个月后,2组血清乙肝病毒DNA载量及丙氨酸氨基转移酶、天冬氨酸氨基转移酶水平下降幅度均无明显差异 ...
doaj  

[APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
You H   +48 more
europepmc   +1 more source

[Chinese expert consensus on infection management in multiple myeloma patients treated with bispecific antibody (2026)]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group   +3 more
europepmc   +1 more source

[Recent advances in epidemiology, prevention and treatment of hepatitis C in China]. [PDF]

open access: yesZhonghua Gan Zang Bing Za Zhi
Yu JJ   +7 more
europepmc   +1 more source

[Incidence and associated factors of anemia within six months after kidney transplantation in pediatric recipients]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Li W   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy